The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Trading Statement

25 Mar 2019 07:00

RNS Number : 7798T
Standard Life Private Eqty Trst PLC
25 March 2019
 

Standard Life Private Equity Trust PLC

 

1. Investment update for the quarter ended 31 December 2018

 

· The net asset value ("NAV") per ordinary share of Standard Life Private Equity Trust PLC ("the Company") decreased by 0.5% to 428.2 pence for the quarter ended 31 December 2018

· Realised gains and income on the unquoted portfolio during the quarter ended 31 December 2018 totalled £11.3 million (1.7% of NAV). The unrealised loss on a constant exchange rate basis was 11.4 million (1.7% of NAV). In addition, there were unrealised foreign exchange gains of £4.9 million (0.7% of NAV)

· The final quarter dividend for the financial year ending 30 September 2018 of 3.1 pence per share was paid on 25 January 2019

· 99.0% by value of the portfolio was valued by the respective underlying managers at 31 December 2018

· NAV total return was 0.1% for the three months from 1 October 2018 to 31 December 2018

· Outstanding commitments were £385.6 million at 31 December 2018

· Resources available for investment were £95.6 million at 31 December 2018

 

For the quarter ended 31 December 2018, the Company's NAV decreased by 0.5% to 428.2 pence per share, from 430.2 pence per share at 30 September 2018. At 31 December 2018, the Company's net assets were £658.3 million (30 September 2018 - £661.4 million). NAV total return was 0.1% for the three months from 1 October 2018 to 31 December 2018.

 

The closing value of the Company's unquoted portfolio, which, included 55 private equity fund interests, was £562.1 million at 31 December 2018 (30 September 2018 - £574.7 million and 55 private equity fund interests). The total unrealised loss on the unquoted portfolio for the quarter ended 31 December 2018 was £6.5 million, comprising £11.4 million of unrealised loss on a constant exchange rate basis and £4.9 million of unrealised foreign exchange gains. The MSCI Europe Index (in sterling) and the FTSE All Share Index (in sterling) both fell by 11% during the quarter. The unrealised foreign exchange gains were driven by the euro and the US Dollar appreciating by 0.8% and 2.3% respectively, relative to sterling over the quarter.

 

During the quarter ended 31 December 2018, the unquoted portfolio generated £28.7 million of distributions (quarter ended 30 September 2018 - £24.4 million). The Company funded £11.4 million of drawdowns (quarter ended 30 September 2018 - £31.0 million) into the unquoted portfolio. The distributions received during the quarter generated £11.3 million of net realised gains and income. The net realised gains and income include the realised loss on written-off investments which were previously already recognised within unrealised losses. Excluding the realised loss on written-off investments, the net realised gains and income was £17.1 million. This was equivalent to a return of 2.5 times the acquisition cost of the realised investments.

 

The Company made one new fund commitment of €30.0 million to Triton V. The Company had total outstanding commitments to its 55 private equity fund interests of £385.6 million at 31 December 2018 (30 September 2018 - £369.3 million to 55 private equity fund interests). The Manager continues to believe that around £60 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 31 December 2018, the Company had resources available for investment of £95.6 million (30 September 2018 - resources available for investment of £86.5 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility provided by Citibank and Societe Generale that expires in December 2020.

 

2. Activity since 31 December 2018

 

On 25 January 2019, the Company paid the final dividend for the year ended 30 September 2018 of 3.1 pence per ordinary share. The cost of the final dividend was £4.8m. In addition, the Company declared a first quarter dividend for the year ending 30 September 2019 of 3.2 pence per share, to be paid on 26 April 2019, to shareholders on the Company's share register as at 22 March 2019. The ex-dividend date is 21 March 2019.

 

During the period from the 1 January 2019 to the 8 March 2019 the Company funded £14.2 million of drawdowns and received £11.8 million of distributions.

 

A new commitment of €35m was made to Altor V on 6 February 2019, and a new co- investment commitment of €6m was made to Mademoiselle Desserts, alongside IK Investment Partners, on 15 February 2019.

 

At 8 March 2019, the Company had resources available for investment of £90.6 million. The Company also had total outstanding commitments of £394.0 million.

 

The Company's estimated NAV at 28 February 2019 is also being announced today. It is anticipated that the Company will release its results for the six months ending 31 March 2019 on or around 19 June 2019.

 

For further information please contact:-

 

Merrick McKay at SL Capital Partners LLP (0131 245 2345)

 

Note:-

Standard Life Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life Private Equity Trust PLC is independent of Standard Life Aberdeen plc and Phoenix Group Holdings.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTELLFLKXFZBBQ
Date   Source Headline
4th Apr 202212:06 pmRNSChange of Name
22nd Mar 20222:14 pmRNSResult of AGM
21st Mar 202211:26 amRNSDirector Declaration
14th Mar 20225:30 pmRNSFTSE Russell Indices
14th Mar 20227:00 amRNSEstimated NAV at 28 February 2022
9th Mar 20222:07 pmRNSFirst Interim Dividend
24th Feb 20227:00 amRNSEdison review on Standard Life Private Equity Trst
14th Feb 20227:00 amRNSEstimated NAV at 31 January 2022
4th Feb 20223:24 pmRNSAnnual Report
1st Feb 202212:45 pmRNSDirector/PDMR Shareholding
27th Jan 20227:05 amRNSEstimated NAV at 31 December 2021
27th Jan 20227:00 amRNSAnnual Financial Report
6th Jan 20229:04 amRNSQuarterly disclosure
15th Dec 20217:00 amRNSEstimated NAV as at 30 November 2021
14th Dec 20213:48 pmRNSFourth Interim Dividend
6th Dec 20217:00 amRNSEdison review on Standard Life Private Equity Trst
12th Nov 20217:00 amRNSEstimated NAV at 31 October 2021
2nd Nov 20214:25 pmRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSEstimated NAV at 30 September 2021
4th Oct 20214:15 pmRNSQuarterly disclosure
29th Sep 20217:02 amRNSEstimated NAV at 31 August 2021
29th Sep 20217:00 amRNSQuarterly Investment Update at 30 June 2021
17th Sep 20211:10 pmRNSUpdate research from QuotedData
7th Sep 20217:00 amRNSThird Interim Dividend
1st Sep 20217:00 amRNSDirectorate Change
16th Aug 202110:19 amRNSDirector/PDMR Shareholding
13th Aug 20217:00 amRNSEstimated NAV at 31 July 2021
10th Aug 20214:41 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
5th Aug 20213:32 pmRNSDirector/PDMR Shareholding
19th Jul 202111:58 amRNSEdison issues review on Standard Life Private
14th Jul 20219:05 amRNSDirector Declaration
14th Jul 20217:00 amRNSEstimated NAV at 30 June 2021
9th Jul 20213:29 pmRNSDoc re. Half yearly report
2nd Jul 20214:35 pmRNSQuarterly disclosure
29th Jun 20217:05 amRNSEstimated NAV at 31 May 2021
29th Jun 20217:00 amRNSHalf-year Report
14th Jun 20212:48 pmRNSSecond Interim Dividend
17th May 20217:00 amRNSEstimated NAV at 30 April 2021
12th May 20214:06 pmRNSDirector/PDMR Shareholding
27th Apr 202112:21 pmRNSDirector/PDMR Shareholding
22nd Apr 20217:05 amRNSEstimated NAV at 31 March 2021
22nd Apr 20217:00 amRNSQuarterly Investment Update at 31 December 2020
9th Apr 202111:58 amRNSHolding(s) in Company
6th Apr 20214:11 pmRNSQuarterly disclosure
23rd Mar 20211:50 pmRNSResult of AGM
12th Mar 20217:00 amRNSEstimated NAV as at 28 February 2021
8th Mar 20217:00 amRNSFirst Interim Dividend
25th Feb 20217:00 amRNSEdison review on Standard Life Private Eqty Trust
12th Feb 202110:22 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.